LSP
Investor profile
Deals
16
distinct rounds
Companies
15
backed
Active span
2016–2022
7 yrs
Total round €
€652M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- GIMV4
- INKEF Capital4
- Versant Ventures3
- Casdin Capital2
- FundPlus2
- Kurma Partners2
- Sunstone Capital2
- Wellington Partners2
- 5AM Ventures1
- Abingworth LLP1
- Agilent Technologies1
- Alexandria Venture Investments1
- Andera Partners1
- Arrowmark Partners1
- Atlantic Bridge1
- BioMedPartners1
- Boehringer Ingelheim Venture Fund1
- Bpifrance Large Venture1
- Bristol Myers Squibb1
- CaaS Capital Management1
- Columbia Threadneedle Investments1
- Coparion1
- Danaher Life Sciences1
- Disruptive Technologies Innovation Fund1
- EIC Accelerator1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| DNA Script | France | 1 | €142M |
| T-knife | Germany | 1 | €94M |
| ViCentra | Netherlands | 1 | €65M |
| Cardior Pharmaceuticals | Germany | 1 | €64M |
| Nouscom | Switzerland | 2 | €54M |
| iSTAR Medical | Belgium | 1 | €40M |
| eTheRNA | Belgium | 1 | €39M |
| OxThera | Sweden | 1 | €32M |
| Onward | Netherlands | 1 | €27M |
| G-Therapeutics | Netherlands | 1 | €26M |
| Imcheck Therapeutics | France | 1 | €20M |
| Vivasure Medical | Ireland | 1 | €16M |
| OneProjects | Ireland | 1 | €15M |
| Xeltis | Switzerland | 1 | €11M |
| Luxendo | Germany | 1 | €8.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| DNA Script | Series C | €142M | 2021-10 |
| T-knife | Series B | €94M | 2021-08 |
| ViCentra | Series C | €65M | 2021-12 |
| Cardior Pharmaceuticals | Series B | €64M | 2021-08 |
| Nouscom | Series B | €42M | 2017-11 |
| iSTAR Medical | Series C | €40M | 2019-06 |
| eTheRNA | Series B | €39M | 2022-08 |
| OxThera | Other | €32M | 2016-10 |
| Onward | Other | €27M | 2021-04 |
| G-Therapeutics | Series A | €26M | 2016-03 |